These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20078445)

  • 21. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does reduced [(123)I]-FP-CIT binding in Huntington's disease suggest pre-synaptic dopaminergic involvement?
    Gamez J; Lorenzo-Bosquet C; Cuberas-Borrós G; Carmona F; Hernández-Vara J; Castilló J; Castell-Conesa J
    Clin Neurol Neurosurg; 2010 Dec; 112(10):870-5. PubMed ID: 20724066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic deficit is not the rule in orthostatic tremor.
    Trocello JM; Zanotti-Fregonara P; Roze E; Apartis E; Legrand AP; Habert MO; Devaux JY; Vidailhet M
    Mov Disord; 2008 Sep; 23(12):1733-8. PubMed ID: 18661569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of neuroimaging in the evaluation of tremor.
    Hensman DJ; Bain PG
    Neuroimaging Clin N Am; 2010 Feb; 20(1):77-86. PubMed ID: 19959020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset.
    Isaias IU; Benti R; Cilia R; Canesi M; Marotta G; Gerundini P; Pezzoli G; Antonini A
    Neuroreport; 2007 Sep; 18(14):1499-502. PubMed ID: 17712282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of nigrostriatal and cerebellothalamic pathways in dopamine responsive Holmes' tremor.
    Seidel S; Kasprian G; Leutmezer F; Prayer D; Auff E
    J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):921-3. PubMed ID: 18450789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with rest-tremor and scans with ipsilateral dopaminergic deficit.
    Aguirregomozcorta M; Stamelou M; Antonini A; Schwingenschuh P; Prvulovich L; Edwards MJ; Dickson JC; Bhatia KP
    J Neurol; 2013 Apr; 260(4):1132-5. PubMed ID: 23196338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levodopa-responsive Holmes' Tremor Caused by a Single Inflammatory Demyelinating Lesion.
    Katschnig-Winter P; Koegl-Wallner M; Pendl T; Fazekas F; Schwingenschuh P
    Tremor Other Hyperkinet Mov (N Y); 2015; 5():339. PubMed ID: 26516604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed tremors with integrity of nigrostriatal system: a clinical and DAT-SPECT follow-up study.
    Arabia G; Novellino F; Morelli M; Paglionico S; Salsone M; Giofrè L; Pucci F; Bagnato A; Cascini GL; Nicoletti G; Messina D; Quattrone A
    Mov Disord; 2010 Apr; 25(5):662-4. PubMed ID: 20108366
    [No Abstract]   [Full Text] [Related]  

  • 30. Patients with scans without evidence of dopaminergic deficit: a long-term follow-up study.
    Batla A; Erro R; Stamelou M; Schneider SA; Schwingenschuh P; Ganos C; Bhatia KP
    Mov Disord; 2014 Dec; 29(14):1820-5. PubMed ID: 25350529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Damage to the central nucleus of the thalamus via atypical Holmes tremor: a case report.
    Zhao H; Shi M; Yang F; Yang D; Hou X; Yang X
    J Int Med Res; 2021 Apr; 49(4):300060521999567. PubMed ID: 33818160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies.
    Söderlund TA; Dickson JC; Prvulovich E; Ben-Haim S; Kemp P; Booij J; Nobili F; Thomsen G; Sabri O; Koulibaly PM; Akdemir OU; Pagani M; van Laere K; Asenbaum-Nan S; George J; Sera T; Tatsch K; Bomanji J
    J Nucl Med; 2013 May; 54(5):714-22. PubMed ID: 23492885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway.
    Zijlmans J; Booij J; Valk J; Lees A; Horstink M
    Mov Disord; 2002 Sep; 17(5):1086-8. PubMed ID: 12360565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rubral tremor of Holmes, rare case of pathological tremor: case report].
    Sławek J; Szymkiewicz-Rogowska A; Friedman A
    Neurol Neurochir Pol; 2000; 34(4):775-82. PubMed ID: 11105309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging Nigrostriatal Dopaminergic Deficit in Holmes Tremor with 18F-PR04.MZ-PET/CT.
    Juri C; Chana P; Kramer V; Pruzzo R; Amaral H; Riss PJ; Rösch F
    Clin Nucl Med; 2015 Sep; 40(9):740-1. PubMed ID: 26204203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
    Zijlmans J; Evans A; Fontes F; Katzenschlager R; Gacinovic S; Lees AJ; Costa D
    Mov Disord; 2007 Jul; 22(9):1278-85. PubMed ID: 17486613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Semiology, Lesion Topography and Treatment Outcomes: A Prospective Study on Post Thalamic Stroke Holmes Tremor.
    Datta AK; Mukherjee A; Malakar S; Biswas A
    J Mov Disord; 2024 Jan; 17(1):71-81. PubMed ID: 37859346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic accuracy of FP-CIT SPECT in patients with parkinsonism].
    Ortega Lozano SJ; Martínez Del Valle Torres MD; Jiménez-Hoyuela García JM; Gutiérrez Cardo AL; Campos Arillo V
    Rev Esp Med Nucl; 2007; 26(5):277-85. PubMed ID: 17910836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of Monosymptomatic Resting Tremor in a Prospective Study: Clinical Features, Electrophysiological Test, and Dopamine Transporter Positron Emission Tomography.
    Zheng HG; Zhang R; Li X; Li FF; Wang YC; Wang XM; Lu LL; Feng T
    Chin Med J (Engl); 2015 Jul; 128(13):1765-71. PubMed ID: 26112718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.